Giuseppe Basso

发表

Frida Rizzati, Barbara Buldini, Giuseppe Basso, 2015, WIREs Data Mining Knowl. Discov..

Standardization of flow cytometric minimal residual disease evaluation in acute lymphoblastic leukemia: Multicentric assessment is feasible

Giuseppe Basso, Richard Ratei, Leonid Karawajew, 2008, Cytometry. Part B, Clinical cytometry.

AIEOP‐BFM Consensus Guidelines 2016 for Flow Cytometric Immunophenotyping of Pediatric Acute Lymphoblastic Leukemia

Barbara Buldini, Giuseppe Basso, Richard Ratei, 2018, Cytometry. Part B, Clinical cytometry.

Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials

Maria Grazia Valsecchi, Arndt Borkhardt, Giuseppe Basso, 1997 .

Adolescent and young adult cancer survivors narrate their stories: Predictive model of their personal growth and their follow-up acceptance.

Giuseppe Basso, Marta Tremolada, G. Basso, 2018, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

Prednisone induces immunophenotypic modulation of CD10 and CD34 in nonapoptotic B‐cell precursor acute lymphoblastic leukemia cells

Andrea Faini, Giuseppe Basso, Richard Ratei, 2008, Cytometry. Part B, Clinical cytometry.

YAP/TAZ Incorporation in the β-Catenin Destruction Complex Orchestrates the Wnt Response

Giuseppe Basso, Silvio Bicciato, Stefano Piccolo, 2014, Cell.

Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia

Barbara Buldini, Giuseppe Basso, Peter Rhein, 2015, Haematologica.

Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia

Govind Bhagat, Satoru Nagase, Teresa Palomero, 2007, Nature Medicine.

Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells.

Paolo Serafini, Frank Brombacher, Giuseppe Basso, 2006, The Journal of clinical investigation.

An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase

Torsten Haferlach, Giuseppe Basso, Robin Foà, 2008, British journal of haematology.

MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures

Giuseppe Basso, G. Basso, A. Zangrando, 2009, BMC Medical Genomics.

Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow.

Maria Grazia Valsecchi, Barbara Buldini, Giuseppe Basso, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

c-kit is expressed in soft tissue sarcoma of neuroectodermic origin and its ligand prevents apoptosis of neoplastic cells.

Alberto L. Horenstein, Giuseppe Basso, Franca Fagioli, 1998, Blood.

Detection of minimal residual disease in pediatric acute lymphoblastic leukemia

Dario Campana, Giuseppe Basso, Andrea Biondi, 2013, Cytometry. Part B, Clinical cytometry.

Determination of extracellular and intracellular pH of Bacillus subtilis suspension under CO2 treatment.

Alberto Bertucco, Giuseppe Basso, Sara Spilimbergo, 2005, Biotechnology and bioengineering.

Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemia.

Andrea Califano, Elisa de Stanchina, Giuseppe Basso, 2013, Cancer cell.

TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis

Marco Presta, Giuseppe Basso, Stefania Mitola, 2013, Angiogenesis.

Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia.

Cheng Cheng, Elaine Coustan-Smith, Dario Campana, 2009, The Lancet. Oncology.

Expression of CD58 in normal, regenerating and leukemic bone marrow B cells: implications for the detection of minimal residual disease in acute lymphocytic leukemia.

Giuseppe Basso, Richard Ratei, Michael N Dworzak, 2003, Haematologica.

New data on robustness of gene expression signatures in leukemia: comparison of three distinct total RNA preparation procedures

Giuseppe Basso, Alexander Kohlmann, A. Kohlmann, 2006, BMC Genomics.

Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer.

Yu Wei, Jean-François Michiels, Giuseppe Basso, 2008, Cancer cell.

miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia.

Giuseppe Basso, Martina Pigazzi, Emma Baron, 2009, Cancer research.

Diagnosis and genetic subtypes of leukemia combining gene expression and flow cytometry.

Giuseppe Basso, G. Basso, M. dell’Orto, 2007, Blood cells, molecules & diseases.

A leukemia-enriched cDNA microarray platform identifies new transcripts with relevance to the biology of pediatric acute lymphoblastic leukemia.

Chiara Romualdi, Nicola Vitulo, Giuseppe Basso, 2005, Haematologica.

LncRNA Expression Discriminates Karyotype and Predicts Survival in B-Lymphoblastic Leukemia

Giuseppe Basso, Martina Pigazzi, David Casero, 2015, Molecular Cancer Research.

Time point-dependent concordance of flow cytometry and real-time quantitative polymerase chain reaction for minimal residual disease detection in childhood acute lymphoblastic leukemia

Maria Grazia Valsecchi, Barbara Buldini, Giuseppe Basso, 2012, Haematologica.

Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options

Thomas Zichner, Adrian M. Stütz, Jan O. Korbel, 2015, Nature Genetics.

Synthesis and biological evaluation of 2-(3',4',5'-trimethoxybenzoyl)-3-aryl/arylaminobenzo[b]thiophene derivatives as a novel class of antiproliferative agents.

Giuseppe Basso, Ernest Hamel, Romeo Romagnoli, 2010, European journal of medicinal chemistry.

Gene expression-based classification as an independent predictor of clinical outcome in juvenile myelomonocytic leukemia.

Franco Locatelli, Giuseppe Basso, G. Basso, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MiR-34a Targeting of Notch Ligand Delta-Like 1 Impairs CD15+/CD133+ Tumor-Propagating Cells and Supports Neural Differentiation in Medulloblastoma

Giuseppe Basso, Achille Iolascon, Giuseppe Cinalli, 2011, PloS one.

γ-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia

Iannis Aifantis, Teresa Palomero, Giuseppe Basso, 2009, Nature Medicine.